Kurt Schrader: “Due to extreme budget cuts, counties are unable to pay for basic services their citizens rely on.”

The BIOSIM Act is a commonsense approach to increase the utilization of biosimilars in this country.

The idea that it is going to cut off all innovation is ridiculous.

We reduce the out-of-pocket expense for seniors to $2,000 a year that they can pay over the course of the year to make it as affordable as possible to them.

That prescription drug bill is an excellent, excellent balance between H.R. 3 and what others would perhaps like to do.